Dynamic MRI provides both structural and functional information in the evaluation of women with lower urinary tract symptoms.
Delayed CE Decreases First Week After AMI

Acute Myocardial Infarction: Serial Cardiac MR Imaging Shows a Decrease in Delayed Enhancement of the Myocardium
During the 1st Week After Reperfusion. Ibrahim T, Hackl T, et al: Radiology 2010; 254 (January): 88-97 After an acute MI that has been reperfused, the extent of delayed contrast enhancement with gadolinium seen on cardiac MRI significantly decreases during the first week after the event.
Background: Delayed contrast-enhanced (CE) cardiac MRI has been shown to demonstrate acute and chronic myocardial infarctions (MIs). The region of infarction demonstrates a delayed washout of contrast compared with normal myocardium. In chronic MI, delayed CE with gadolinium is closely related to scar tissue. In acute and subacute MI, it is less well defined. Objective: To evaluate delayed gadolinium enhancement by serial cardiac MRI during the acute, subacute, and chronic stages of MI. Participants: Patients had an acute myocardial infarction (AMI) and had undergone coronary reperfusion via a stent placed within 12 hours after symptoms began. AMI was diagnosed by the presence of chest pain lasting ≥20 minutes associated with ECG changes; 17 patients were studied. Methods: Cardiac MRI was performed at 1, 7, 35, and 180 days after AMI. SPECT imaging at rest was also performed in all patients 7 days after AMI. Cardiac MRI was performed using a 1.5-T magnet. CE cardiac MRI was performed 20 minutes after injection of 0.2 mmol/kg of gadopentetate dimeglumine with a 3D segmented inversion-recovery turbo fast low-angle shot T1-weighted sequence. Short-and long-axis images were evaluated for the size of delayed enhancement as well as percentage of left ventricular (LV) myocardial volume. The transmural extent of CE was also evaluated. Endocardial and epicardial contours were manually drawn. The endocardium was considered the inner 50% and the epicardium was considered the outer 50% of the myocardial wall.
Results:
The size of infarct was 18.3% of total myocardial LV volume on the first day after AMI. The size was 12.9% after 7 days, 11.3% after 35 days, and 11.6% after 180 days. The size of the infarct decreased by 57.1% in the epicardium and 6.3% within the endocardium from day 1 to day 7. There was a high correlation (r =0.84) of infarct size between cardiac MRI and SPECT on day 7.
Conclusions:
The extent of delayed CE on cardiac MRI significantly decreases during the first week after reperfusion.
Reviewer's Comments:
The authors have very nicely demonstrated that the timing of cardiac MRI after infarction and successful reperfusion will affect the apparent size of the infarction as seen on delayed CE sequences. This is particularly true in the first week after the event when there is a relatively large decrease in the area of delayed CE. (Reviewer-Vineet R. Jain, MD).
Percutaneous Biopsy in the Elderly
Percutaneous Image-Guided Biopsy in an Elderly Population. Percutaneous biopsy in the elderly is just as safe and is only slightly less accurate than biopsies in younger patients, but it leads to less initiation of cancer therapy.
Background: Percutaneous image-guided biopsy is a safe, efficacious procedure. In patients aged ≥80 years, there are many comorbidities that may make image-guided biopsy less safe. These same morbidities may also make the treatment of whatever pathology is found difficult to treat. Objective: To evaluate (1) the safety and accuracy of percutaneous biopsy performed in patients aged ≥80 years, and (2) how much the results of these biopsies are used to initiate therapy. Methods: In the authors' institution, a retrospective review of all CT-and/or US-guided biopsies done over a 5-year period was performed. Of the almost 14,000 patients biopsied with image guidance, 722 were aged ≥80 years. The rates of complications were compared with the same rates in those aged ≤79 years (13,022 patients).
Results: There were no statistically significant differences in complication rates between the ≥80 years group (1.5%) compared to the ≤79 years group (1.4%). The accuracy rate was slightly higher for the younger group (96.5%) than for the elderly group (95%). The most common biopsy locations in the elderly were liver (23%), lung (17%), and soft tissue/musculoskeletal (16%). In the elderly group, 75.8% of the biopsies yielded malignant diagnoses. In this group of 467 patients with malignant diagnoses, only 58% initiated therapy for their disease. Compared to younger patients, 100% of the 60-to 70-year-old group initiated therapy. In the 70-to 80-year-old group, 95% initiated therapy. Image guidance techniques also differed between groups. In elderly patients, 57% of the procedures were performed with CT and the rest with US. In the younger patients, 30% of procedures were performed with CT and the rest with US. Reviewer's Comments: Image-guided biopsy in the elderly has a high accuracy rate and is as safe as biopsy performed in those aged ≤79 years. The authors believe that the slightly lower accuracy seen in elderly patients may be related to the fact that they had a greater percentage of lung and lymph node biopsies, which tend to be less accurate. Cancer mortality is decreasing in the younger population but increasing in the older age groups. Cancer therapy has less predictable effects in the elderly. Elderly patients with excellent performance status and a high quality of life have similar results to their younger counterparts to many types of cancer therapies. The significantly lower percentage of patients who started therapy because of malignant diagnoses was usually secondary to poor medical condition because of other comorbid diseases. Another reason was the patient's desire to choose a better quality of life that may be limited rather than aggressive, potentially damaging therapy. (Reviewer-Sharon Gonzales, MD). Furosemide administered either 15 or 45 minutes following 18F-FDG resulted in SUV max that were 3-fold less than in control patients not administered a diuretic.
Furosemide and Oncologic PET/CT
Background: Intense pelvic bladder activity from excreted 18F-fluorodeoxyglucose (18F-FDG) can obscure adjacent pelvic pathology. Diuretic administration has been used to try and dilute the bladder activity and promote voiding. Objective: To study the effects of 2 variations of a furosemide protocol as compared to a control group not administered a diuretic. Design: Retrospective analysis. Participants: 109 patients with known or suspected malignancy were included in the study. Of these patients, 39 received 20 mg of furosemide 45 minutes following 18 F-FDG administration (15 minutes prior to imaging), and 45 patients were administered furosemide 15 minutes following 18F-FDG (45 minutes prior to imaging). The third group, consisting of 25 patients, did not receive furosemide.
Methods: Elliptical regions of interest were placed to approximate the interior bladder volume. Mean and peak standard uptake values (SUVs) were obtained. The bladder size was visually compared to the bladder size on CT. The mean SUV of a region within the right lobe of the liver was also used to normalize the bladder average SUV.
Results: Imaging was interrupted because of urinary urgency in 2 patients when furosemide was given later, at 45 minutes following 18F-FDG, but not when given early, at 15 minutes following 18F-FDG, nor in the control groups. There was no significant difference in bladder intensity between the 2 diuretic groups; however, maximum SUV (SUV max ) were lower by a factor of 3 and mean SUV (SUV mean ) were lower by a factor of 2 as compared to controls. When the mean bladder SUV was normalized by the mean liver SUV, the early furosemide group had a slightly lower ratio than the late furosemide group. Bladder volumes were greater in the furosemide groups than in the control group, and the early furosemide group had relatively larger mean bladder volumes than the late furosemide group. The furosemide groups had greater misregistration between emission and CT bladder images than the control group, and this was greatest when furosemide was given earlier. In several cases, the authors state that the lower bladder activity following furosemide facilitated discrimination between urine, bladder wall abnormalities, and surrounding structures. Conclusions: Diuretic did increase bladder volume and lower concentration of bladder activity to the point where it became easier to discriminate bladder wall and surrounding activity from the bladder itself. Early furosemide was better tolerated (ie, with less interrupted acquisitions) than late furosemide, and bladder volumes and degree of misregistration were larger. Reviewer's Comments: One oddity in this paper was that the patients were given saline following 18F-FDG administration, which is not a standard technique. That may make it difficult to generalize the findings described herein to patients not hydrated in the same manner. (Reviewer-Lionel S. Zuckier, MD).
